BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 1, 2007
View Archived Issues
Investigational prokinetic 5-HT4 agonist advancing through the pipeline
Read More
Support for activation of SIRT1 as a novel approach to type 2 diabetes
Read More
Cadence increases enrollment of phase III trial of Omigard for LCSI reduction
Read More
Quigley Pharma initiates clinical trial of QR-449 for metabolic syndrome
Read More
Positive results for Phytopharm's liquid formulation of Myogane
Read More
Elan announces second quarter 2007 results
Read More
Positive results for Biolex's phase IIa trial of Locteron for hepatitis C
Read More
Ranbaxy claims new drugs for respiratory disorders
Read More
New treatment options for dermatological disorders divulged in recent patent
Read More
Recent patent literature discloses new antiobesity drugs
Read More
EvaMist approved by the FDA
Read More
Symposium features Sirtex's SIR-Spheres for colorectal liver metastases
Read More
Anadys and Novartis discontinue development of ANA-975 for HCV
Read More
Abbott voluntarily withdraws E.U. marketing authorization for Trudexa
Read More
Targacept initiates phase I clinical trial of TC-5619
Read More
ReNeuron acquires business assets from AmCyte
Read More
Threshold begins phase I trial of TH-302 for solid tumors
Read More
Regulatory update on satraplatin
Read More
GSK and Targacept to codevelop novel NNRs targeting therapeutics
Read More
Toyama receives marketing approval for Geninax in Japan
Read More
Clinical evaluation to commence for a new agent for hyperlipidemia
Read More
Eisai to begin trial to determine MTD of E-7107 in cancer patients
Read More
Elixir presents data on ghrelin- and sirtuin-based programs for metabolic diseases
Read More
Fludarabine plus cyclophosphamide for the treatment of CLL
Read More
First small-molecule HIV-1 Tat-PP-1 inhibitors designed to inhibit HIV-1 transcription described
Read More
Comparison of different formulations of mycophenolic acid in IgA nephritis
Read More